Pharmaceuticals

Jupiter Neurosciences

Jupiter Neurosciences released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 50K), actual EPS USD -0.0672

Jupiter Neurosciences released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.1833

Jupiter Neurosciences released FY2025 Semi-Annual earnings on August 19 (EST), with actual revenue of USD 0 and EPS of USD -0.1132

Jupiter Neurosciences released FY2025 Q2 earnings on August 19 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.07 (forecast USD --)

Jupiter Neurosciences released FY2025 Q1 earnings on May 15 (EST) with actual revenue of USD 0 and EPS of USD -0.0461

Jupiter Neurosciences Inc plans to start Phase 2A clinical trial for JNS115 for Parkinson's disease in Q3 2025

Jupiter Neurosciences released FY2024 annual earnings on March 28 (EST), with actual revenue of 0 USD and EPS of -0.0847 USD

Jupiter Neurosciences released FY2024 Q4 earnings on March 28 (EST), actual revenue 0 USD, actual EPS -0.0482 USD

Jupiter Neurosciences released FY2023 Q4 earnings on March 28 (EST) with actual revenue of 0 USD and EPS of -0.02 USD

Jupiter Neurosciences released FY2023 Q3 earnings on December 23 (EST) with actual revenue of 0 USD and EPS of -0.07 USD

Jupiter Neurosciences released FY2024 9 Months Earnings on December 23 (EST), with actual revenue of USD 0 and EPS of USD -0.0329

Jupiter Neurosciences released FY2024 Q3 earnings on December 23, 2024 (EST), with actual revenue of USD 0 and EPS of USD -0.019

Jupiter Neurosciences released FY2023 9 Months Earnings on December 23, 2024 (EST) with actual revenue of 0 USD and EPS of -0.1677 USD

Jupiter Neurosciences released FY2024 Q2 earnings on September 4, 2024 (EST), with actual revenue of 0 USD and EPS of 0.0099

Jupiter Neurosciences released FY2023 Q2 earnings on September 4, 2024 (EST), with actual revenue of 0 and EPS of -0.0315

Jupiter Neurosciences released FY2024 H1 earnings on September 4, 2024 (EST) with revenue of 0 USD and EPS of -0.0117

Jupiter Neurosciences released FY2023 H1 earnings on September 4, 2024 (EST), with revenue of 0 USD and EPS of -0.1

Jupiter Neurosciences released FY2024 Q1 earnings on July 12, 2024 (EST) with revenue of 0 USD and EPS of -0.0239

Jupiter Neurosciences released FY2023 Q1 earnings on July 12, 2024 (EST), with actual revenue of 0 USD and EPS of -0.0662

Jupiter Neurosciences released FY2023 Annual Earnings on July 12, 2024 (EST), Revenue: 0, EPS: -0.1811

A SPAC III Acquisition

PicoCELA

Davis Commodities

Society Pass

ECD Automotive Design

Gauzy

Bristol-Myers Squibb Company

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

Paranovus ENT Tech

Cue BioPharma

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap